|
Real-time Estimate
Tradegate
12:02:23 21/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.7580 EUR | -1.30% |
|
+1.32% | - |
| 08-17 | Valerio Therapeutics Nears Final Deal for Etherna Immunotherapies Purchase | MT |
| 07-16 | Valerio Therapeutics, Abivax Enter R&D Collaboration for Inflammatory Disease Therapies | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 449M | - | - | - | - | - |
| 1,109B | |||||
| 644B | - | - | - | ||
| 463B | |||||
| 371B | |||||
| 301B |
Select your edition
All financial news and data tailored to specific country editions
